During the past decade, UChicago Medicine Comprehensive Cancer Center - Saint Joseph Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 9 clinical trials were completed, i.e. on average, 450% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UChicago Medicine Comprehensive Cancer Center - Saint Joseph Hospital" #1 collaborator was "NRG Oncology" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "UChicago Medicine Comprehensive Cancer Center - Saint Joseph Hospital" are "Breast Adenocarcinoma" (2 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (2 trials), "Fallopian Tube Transitional Cell Carcinoma" (2 trials), "Fallopian Tube Undifferentiated Carcinoma" (2 trials) and "Ovarian Clear Cell Adenocarcinoma" (2 trials). Many other conditions were trialed in "UChicago Medicine Comprehensive Cancer Center - Saint Joseph Hospital" in a lesser frequency.

Most popular intervention types in "UChicago Medicine Comprehensive Cancer Center - Saint Joseph Hospital" are "Other" (10 trials), "Drug" (9 trials), "Biological" (6 trials), "Radiation" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Bevacizumab" (4 trials), "Doxorubicin Hydrochloride" (3 trials), "Paclitaxel" (3 trials) and "Quality-of-Life Assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "UChicago Medicine Comprehensive Cancer Center - Saint Joseph Hospital" are 7 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UChicago Medicine Comprehensive Cancer Center - Saint Joseph Hospital". undefined are not yet recruiting, undefined are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UChicago Medicine Comprehensive Cancer Center - Saint Joseph Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UChicago Medicine Comprehensive Cancer Center - Saint Joseph Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".